9.79
-0.11
(-1.11%)
At close: January 31 at 4:00:02 PM EST
10.08
+0.29
+(2.96%)
After hours: January 31 at 6:49:33 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 91.35k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 17.48 - 22.23 per share. | Indirect | 7,003,761 | Sep 20, 2024 |
| KUNG WINSTON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 16, 2024 |
| MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security at price 4.26 - 30.00 per share. | Direct | 233,820 | Jun 18, 2024 |
| COHEN YUVAL Chief Executive Officer | Conversion of Exercise of derivative security at price 4.26 - 30.00 per share. | Direct | 962,887 | Jun 18, 2024 |
| MORAN SEAN F Chief Financial Officer | Sale at price 42.12 - 49.87 per share. | Direct | 863,838 | Jun 18, 2024 |
| COHEN YUVAL Chief Executive Officer | Sale at price 42.24 - 50.17 per share. | Direct | 2,950,518 | Jun 18, 2024 |
| HOLMER ALAN F Director | Conversion of Exercise of derivative security at price 30.00 per share. | Direct | 50,010 | Jun 14, 2024 |
| CATLIN AVERY W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| HOLMER ALAN F Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| JENKINS JOHN KENNETH M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| JACQUES RACHELLE SUZANNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| SALZMANN PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| ALTMEYER ANNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| BEN YONG Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security at price 30.00 per share. | Direct | 53,610 | Apr 10, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 37.82 - 45.96 per share. | Indirect | 23,327,560 | Mar 8, 2024 |
| SMETHURST DOMINIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2024 |
| MORAN SEAN F Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| COHEN YUVAL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 26.72 per share. | Indirect | 20,040,000 | Feb 2, 2024 |
| HOLMER ALAN F Director | Conversion of Exercise of derivative security at price 4.97 per share. | Direct | 3,126 | Jan 26, 2024 |
| COHEN YUVAL Chief Executive Officer | Conversion of Exercise of derivative security at price 4.97 per share. | Direct | 35,680 | Jan 26, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 25.73 - 34.62 per share. | Indirect | 8,412,311 | Jan 26, 2024 |
Related Tickers
VTYX Ventyx Biosciences, Inc.
2.0100
-1.95%
OKUR OnKure Therapeutics, Inc.
6.15
+5.49%
NERV Minerva Neurosciences, Inc.
2.3100
-2.94%
TIL Instil Bio, Inc.
22.26
-7.29%
KROS Keros Therapeutics, Inc.
11.40
-2.65%
ASMB Assembly Biosciences, Inc.
14.01
-2.91%
CGEM Cullinan Therapeutics, Inc.
10.56
-3.83%
DYN Dyne Therapeutics, Inc.
14.22
+0.57%
CLRB Cellectar Biosciences, Inc.
0.2514
+0.96%
SPRO Spero Therapeutics, Inc.
0.8566
-1.54%